Year 2020 / Volume 112 / Number 12
Original
Percutaneous transhepatic cholangiography and drainage and endoscopic retrograde cholangiopancreatograph for hilar cholangiocarcinoma: which one is preferred?

893-897

DOI: 10.17235/reed.2020.6937/2020

Jianghong Zhu, Huang Feng, Deqing Zhang, Rui Li, Jing Li, Hongwei Peng, Wen Tang, Duanmin Hu, Wei Wu, Kewei Hu, Wei Cai, Guojian Yin,

Abstract
Introduction: both percutaneous transhepatic cholangiography and drainage (PTCD) and endoscopic retrograde cholangiopancreatography (ERCP) with SEMS implantation have been used for unresectable hilar cholangiocarcinoma (HC) in the clinic for many years. However, which one is preferred is still unknown. Objective: to study the effects of biliary drainage of self-expanding metal stents (SEMS) implantation under PTCD or ERCP to treat HC. Methods: the clinical data of 82 patients with HC from January 2006 to January 2015 were recorded retrospectively. Patients were treated with biliary implantation of self-expanding metal stents (SEMS) under PTCD (PTCD group, 40 patients) or ERCP (ERCP group, 42 patients). Clinical data, including total bilirubin concentrations, complications and survival time were analyzed. Results: the remission of jaundice was similar in both groups (p > 0.05). The median survival time of the ERCP group and PTCD group were 237 d and 252 d respectively, with no significant differences (p > 0.05). The biliary infection rates under ERCP and PTCD procedure were 52.4 % and 20.0 % respectively, with a significant statistical difference (p < 0.05). For those HC patients of Bismuth III/IV, the infection rates under ERCP and PTCD procedure were 58.3 % and 14.3 %, respectively (p < 0.05). Conclusions: both PTCD and ERCP with SEMS implantation were effective to prolong the survival time of HC patients. The biliary infection rates were higher in the ERCP group, especially for Bismuth III/IV HC patients.
Share Button
New comment
Comments
No comments for this article
References
1. Clary B, Jarnigan W, Pitt H, et al. Hilar cholangiocarcinoma. J Gastrointest Surg 2004;8:298-302.
2. Kang MJ, Jang JY, Chang J, et al. Actual Long-Term Survival Outcome of 403 Consecutive Patients with Hilar Cholangiocarcinoma. World J Surg 2016;40:2451-9.
3. Yamane S, Katada C, Tanabe S, et al. Clinical Outcomes in Patients with Cancer of Unknown Primary Site Treated By Gastrointestinal Oncologists. J Transl Int Med 2017;5:58-63.
4. Conio M, Demarquay JF, De Luca L, et al. Endoscopic treatment of pancreatico-biliary malignancies. Crit Rev Oncol Hematol 2001;37:127-35.
5. Tuqan W, Innabi A, Alawneh A, et al. Prediction of Survival Following Percutaneous Biliary Drainage for Malignant Biliary Obstruction. J Transl Int Med 2017;5:127-131.
6. Squadroni M, Tondulli L, Gatta G, et al. Cholangiocarcinoma. Crit Rev Oncol Hematol 2017;116:11-31.
7. Chen KJ, Yang FC, Qin YS, et al. Assessment of clinical outcomes of advanced hilar cholangiocarcinoma. Hepatobiliary Pancreat Dis Int 2018;17:155-162.
8. Nakai Y, Yamamoto R, Matsuyama M, et al. Multicenter study of endoscopic preoperative biliary drainage for malignant hilar biliary obstruction: E-POD hilar study. J Gastroenterol Hepatol 2018;33:1146-1153.
9. Tang K, Sui LL, Xu G, et al. Effects of Different Palliative Jaundice Reducing Methods on Immunologic Functions in Patients with Advanced Malignant Obstructive Jaundice. Anticancer Res 2017;37:4665-4670.
10. Xu C, Lv PH, Huang XE, et al. Analysis of different ways of drainage for obstructive jaundice caused by hilar cholangiocarcinoma. Asian Pac J Cancer Prev 2014;15:5617-20.
11. Stern N, Sturgess R. Endoscopic therapy in the management of malignant biliary obstruction. Eur J Surg Oncol 2008;34:313-7.
12. Park YJ, Kang DH. Endoscopic drainage in patients with inoperable hilar cholangiocarcinoma. Korean J Intern Med 2013;28:8-18.
13. Menon S. Stent placement for hilar cholangiocarcinoma. Gastrointest Endosc 2018;87:905-906.
14. Easler JJ, Sherman S, Cote GA. Optimizing palliation of malignant hilar strictures by the use of endobiliary stents. Gastrointest Endosc 2017;86:828-830.
15. Koshitani T, Nakagawa S, Itoh Y. Multiple self-expandable metal stent deployment for unresectable malignant hilar biliary strictures: Combination of side-by-side and stent-in-stent methods. Dig Endosc 2016;28:621.
16. Inoue T, Okumura F, Naitoh I, et al. Feasibility of the placement of a novel 6-mm diameter threaded fully covered self-expandable metal stent for malignant hilar biliary obstructions (with videos). Gastrointest Endosc 2016;84:352-7.
17. Nakai Y, Isayama H, Matsubara S, et al. Conversion of transpapillary drainage to endoscopic ultrasound-guided hepaticogastrostomy and gallbladder drainage in a case of malignant biliary obstruction with recurrent cholangitis and cholecystitis (with videos). Endosc Ultrasound 2017;6:205-207.
18. Mukai S, Itoi T. How should we use endoscopic ultrasonography-guided biliary drainage techniques separately? Endosc Ultrasound 2016;5:65-8.
19. Grunhagen DJ, Dunne DF, Sturgess RP, et al. Metal stents: a bridge to surgery in hilar cholangiocarcinoma. HPB (Oxford) 2013;15:372-8.
20. Rerknimitr R, Angsuwatcharakon P, Ratanachu-ek T, et al. Asia-Pacific consensus recommendations for endoscopic and interventional management of hilar cholangiocarcinoma. J Gastroenterol Hepatol 2013;28:593-607.
21. Raju RP, Jaganmohan SR, Ross WA, et al. Optimum palliation of inoperable hilar cholangiocarcinoma: comparative assessment of the efficacy of plastic and self-expanding metal stents. Dig Dis Sci 2011;56:1557-64.
22. Cao G, Yang R. [Long-term retrospective analysis of metallic stents in malignant biliary obstruction]. Beijing Da Xue Xue Bao Yi Xue Ban 2008;40:121-4.
23. Liu JG, Wu J, Wang J, et al. Endoscopic Biliary Drainage Versus Percutaneous Transhepatic Biliary Drainage in Patients with Resectable Hilar Cholangiocarcinoma: A Systematic Review and Meta-Analysis. J Laparoendosc Adv Surg Tech A 2018.
24. Kawakubo K, Kawakami H, Kuwatani M, et al. Lower incidence of complications in endoscopic nasobiliary drainage for hilar cholangiocarcinoma. World J Gastrointest Endosc 2016;8:385-90.
25. Goenka MK, Goenka U. Palliation: Hilar cholangiocarcinoma. World J Hepatol 2014;6:559-69.
26. Freeman ML, Sielaff TD. A modern approach to malignant hilar biliary obstruction. Rev Gastroenterol Disord 2003;3:187-201.
27. Lu J, Guo JH, Zhu HD, et al. Palliative treatment with radiation-emitting metallic stents in unresectable Bismuth type III or IV hilar cholangiocarcinoma. ESMO Open 2017;2:e000242.
28. Hu B, Zhou D, Gong B, et al. [Clinical application of expandable metal stent for palliation of malignant biliary obstruction]. Zhonghua Wai Ke Za Zhi 1999;37:282-5.
29. Inamdar S, Slattery E, Bhalla R, et al. Comparison of Adverse Events for Endoscopic vs Percutaneous Biliary Drainage in the Treatment of Malignant Biliary Tract Obstruction in an Inpatient National Cohort. JAMA Oncol 2016;2:112-7.
30. Hameed A, Pang T, Chiou J, et al. Percutaneous vs. endoscopic pre-operative biliary drainage in hilar cholangiocarcinoma - a systematic review and meta-analysis. HPB (Oxford) 2016;18:400-10.
31. Gerges C, Schumacher B, Terheggen G, et al. Expandable metal stents for malignant hilar biliary obstruction. Gastrointest Endosc Clin N Am 2011;21:481-97, ix.
32. Sangchan A, Chaiyakunapruk N, Supakankunti S, et al. Cost utility analysis of endoscopic biliary stent in unresectable hilar cholangiocarcinoma: decision analytic modeling approach. Hepatogastroenterology 2014;61:1175-81.
33. Sangchan A, Kongkasame W, Pugkhem A, et al. Efficacy of metal and plastic stents in unresectable complex hilar cholangiocarcinoma: a randomized controlled trial. Gastrointest Endosc 2012;76:93-9.
34. Yi B, Zhang BH, Zhang YJ, et al. Surgical procedure and prognosis of hilar cholangiocarcinoma. Hepatobiliary Pancreat Dis Int 2004;3:453-7.
35. Paik WH, Park YS, Hwang JH, et al. Palliative treatment with self-expandable metallic stents in patients with advanced type III or IV hilar cholangiocarcinoma: a percutane
Related articles

Letter

Acute cholecystitis treated by direct visualization endoscopy

DOI: 10.17235/reed.2023.9432/2022

Editorial

Fewer endoscopists should perform more ERCPs

DOI: 10.17235/reed.2023.9507/2022

Letter

ERCP and situs inversus

DOI: 10.17235/reed.2021.8374/2021

Digestive Diseases Image

A rare case of acute obstructive suppurative pancreatic ductitis associated with ERCP

DOI: 10.17235/reed.2018.5756/2018

Editorial

Pancreatic stents in ERCP. Where are we?

DOI: 10.17235/reed.2018.5670/2018

Letter to the Editor

Me, the intruder: revisited and rethought

DOI: 10.17235/reed.2018.5575/2018

Letter

Obstructive jaundice secondary to a hepatic hydatid cyst

DOI: 10.17235/reed.2018.5574/2018

Editorial

Pursuing excellence in ERCP

DOI: 10.17235/reed.2018.5373/2017

Letter to the Editor

A post-endoscopic retrograde cholangiopancreatography subcapsular hepatic hematoma

DOI: 10.17235/reed.2017.5123/2017

Letter to the Editor

Accuracy of ASGE criteria for the prediction of choledocholithiasis

DOI: 10.17235/reed.2017.4511/2016

Case Report

Hepatic hematoma after ERCP: two new case reports

DOI: 10.17235/reed.2017.4237/2016

Digestive Diseases Image

Successive breaks in biliary stents

Citation tools
Zhu J, Feng H, Zhang D, Li R, Li J, Peng H, et all. Percutaneous transhepatic cholangiography and drainage and endoscopic retrograde cholangiopancreatograph for hilar cholangiocarcinoma: which one is preferred?. 6937/2020


Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics
This article has received 746 visits.
This article has been downloaded 473 times.

Statistics from Dimensions


Statistics from Plum Analytics

Publication history

Received: 03/02/2020

Accepted: 28/03/2020

Online First: 29/10/2020

Published: 09/12/2020

Article revision time: 38 days

Article Online First time: 269 days

Article editing time: 310 days


Share
This article has been rated by 1 readers.
Reader rating:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
The Spanish Journal of Gastroenterology is the official organ of the Sociedad Española de Patología Digestiva, the Sociedad Española de Endoscopia Digestiva and the Asociación Española de Ecografía Digestiva
Cookie policy Privacy Policy Legal Notice © Copyright 2023 y Creative Commons. The Spanish Journal of Gastroenterology